Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (135)	2/1/1998 4:14:00 PM
From: Mark Adams	Read Replies (1) of 186

Re the US as a source of antibiotic resitant bugs- it is true that we export these to the third world areas, where they mulitply and in some cases mutate due to the lower level of detection and treatment available. It's also true that stores of previously unkown bugs exist in remote areas which can become resitant due to improper use of antibiotics by underequiped or undertrained doctors in the area. I don't know all the plays available in the area- but I think more companies are working on this than we realize, some with sizable research budgets. The key today is the advanced research methods being developed over the past few years and hopefully into the future. The biggest potential roadblock would be the time required to determine safety and effectiveness. The best defense as an individual is to learn how to maximize one's immune system- which in reality does the majority of the defense work (aided by medical technology). I would be interested in hearing about other Companies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next